Bello Angelica M, Wasilewski Ewa, Wei Lianhu, Moscarello Mario A, Kotra Lakshmi P
Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada ; Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada ; Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto , Toronto, Ontario, M5S 3M2, Canada.
Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada ; Center for Molecular Design and Preformulations and Toronto General Research Institute, University Health Network , Toronto, Ontario, M5G 1L7, Canada.
ACS Med Chem Lett. 2013 Jan 15;4(2):249-53. doi: 10.1021/ml300377d. eCollection 2013 Feb 14.
Protein arginine deiminases (PADs) are involved in a number of cellular pathways, and they catalyze the transformation of peptidyl arginine residue into a citrulline as part of post-translational modifications. To understand ligand preferences, a group of probe molecules were investigated against PAD1, PAD2, and PAD4. These probe molecules carried a well-known covalent modifier of the catalytic cysteine residue, 2-chloroacetamidine moiety, which was tethered to an α-amino acid via a carbon linker. The chain length for the linker varied from 0 to 4. Time-dependent assays indicated that 2-chloroacetamidine (2CA) with no linker inhibited all PAD enzymes with a similar trend in the second-order rate constants, although with poor affinity. Among the other three probe molecules, compound 3 with a three-carbon linker exhibited the best second-order rate constants for optimal ligand reactivity with the binding site. These analyses provide insights into the relative patterns of covalent inactivation of PAD isozymes and the design of novel inhibitors targeting PAD enzymes as potential therapeutic targets.
蛋白质精氨酸脱亚氨酶(PADs)参与多种细胞途径,作为翻译后修饰的一部分,它们催化肽基精氨酸残基转化为瓜氨酸。为了解配体偏好,研究了一组针对PAD1、PAD2和PAD4的探针分子。这些探针分子带有催化性半胱氨酸残基的著名共价修饰剂2-氯乙脒部分,该部分通过碳连接子与α-氨基酸相连。连接子的链长从0到4不等。时间依赖性分析表明,没有连接子的2-氯乙脒(2CA)以相似的趋势抑制所有PAD酶,尽管亲和力较差,但二级速率常数相似。在其他三个探针分子中,具有三碳连接子的化合物3表现出最佳的二级速率常数,以实现与结合位点的最佳配体反应性。这些分析为PAD同工酶共价失活的相对模式以及靶向PAD酶作为潜在治疗靶点的新型抑制剂的设计提供了见解。